Epiboneincis A Clinical Stage Regenerative Medicine Company Based In Brooklynnew Yorkspecializing In Personalized Bone And Cartilage Reconstruction Through Advanced Tissue Engineeringfounded In 2013Epibone Focuses On Creating Patient Specific Skeletal Grafts Using Stem Cell Technologythe Company Is Currently In The Series A Funding Stage And Has Raised Over $61 Million To Support Its Innovative Work Epibone S Proprietary Process Includes Creating 3D Models Of Bone Defectsharvesting Stem Cells From Patientsand Culturing Bone And Cartilage In Bioreactorsthis Results In Custom Grafts That Are Anatomically Precise And Biocompatibleminimizing Risks Associated With Traditional Implantsthe Company Develops Custom Bone Graftscartilage And Composite Grafts For Various Reconstructive Needsand Bioreactor Systems For Tissue Productionepibone Aims To Serve Healthcare Providers And Patients Facing Skeletal Reconstruction Challengesoffering Solutions That Replace Conventional Methods Like Metal Implants
